Among these, PD-L1, as the primary ligand for PD-1, is commonly upregulated in tumor cells and also expressed in B cells, T cells, dendritic cells, macrophages, bone marrow-derived mast cells, and some non-immune cells 14. The gene discussed is SNCA; the disease is neoplasm.